Key result
Next-generation sequencing identifies a mosaic CACNA1C mutation in ~18% of cells missed by Sanger sequencing.
Why the study?
Does next-generation sequencing identify mosaic mutations in patients with suspected Timothy syndrome when conventional Sanger sequencing is negative?
Case Report (n=1)
Does next-generation sequencing identify mosaic mutations in patients with suspected Timothy syndrome when conventional Sanger sequencing is negative?
Next-generation sequencing is crucial for identifying mosaic mutations in suspected Timothy syndrome when conventional Sanger sequencing is negative.
Mosaicism may explain variable long QT severity; leaves open need for sensitive genetic testing in syndromic cases.
Autosomal dominant genetic diseases can occur de novo and in the form of somatic mosaicism, which can give rise to a less severe phenotype, and make diagnosis more difficult given the sensitivity limits of the methods used. We report the case of female child with a history of surgery for syndactyly of the hands and feet, who was admitted at 6 years of age to a pediatric intensive care unit following cardiac arrest. The electrocardiogram (ECG) showed a long QT interval that on occasions reached 500 ms. Despite the absence of facial dysmorphism and the presence of normal psychomotor development, a diagnosis of Timothy syndrome was made given the association of syndactyly and the ECG features. Sanger sequencing of the CACNA1C gene, followed by sequencing of the genes KCNQ1, KCNH2, KCNE1, KCNE2, were negative. The subsequent analysis of a panel of genes responsible for hereditary cardiac rhythm disorders using Haloplex technology revealed a recurrent mosaic p.Gly406Arg missense mutation of the CACNA1C gene in 18% of the cells. This mosaicism can explain the negative Sanger analysis and the less complete phenotype in this patient. Given the other cases in the literature, mosaic mutations in Timothy syndrome appear more common than previously thought. This case demonstrates the importance of using next-generation sequencing to identify mosaic mutations when the clinical picture supports a specific mutation that is not identified using conventional testing.
No takes yet. Share an insight, caveat, or question.
Baurand et al. (2016) conducted a case report in Incomplete Timothy syndrome (n=1). Next-generation sequencing vs. Sanger sequencing was evaluated on Identification of genetic mutation. Next-generation sequencing successfully identified a recurrent mosaic p.Gly406Arg missense mutation of the CACNA1C gene in 18% of cells after conventional Sanger sequencing was negative.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: